MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

Current stock price

7.9 EUR
0 (0%)
Last:

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKS has reported negative net income.
  • ALMKS had a positive operating cash flow in the past year.
  • In the past 5 years ALMKS reported 4 times negative net income.
  • Of the past 5 years ALMKS 4 years had a positive operating cash flow.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • ALMKS has a worse Return On Assets (-0.94%) than 64.06% of its industry peers.
  • ALMKS has a worse Return On Equity (-4.48%) than 62.50% of its industry peers.
  • ALMKS has a Return On Invested Capital of 7.00%. This is in the better half of the industry: ALMKS outperforms 67.19% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALMKS is below the industry average of 7.57%.
  • The last Return On Invested Capital (7.00%) for ALMKS is above the 3 year average (2.93%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROIC 7%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

1.3 Margins

  • ALMKS's Profit Margin has improved in the last couple of years.
  • ALMKS's Operating Margin of 1.87% is in line compared to the rest of the industry. ALMKS outperforms 42.19% of its industry peers.
  • In the last couple of years the Operating Margin of ALMKS has declined.
  • Looking at the Gross Margin, with a value of 20.58%, ALMKS is doing worse than 79.69% of the companies in the same industry.
  • ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.58%
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALMKS is creating some value.
  • The number of shares outstanding for ALMKS has been increased compared to 1 year ago.
  • The number of shares outstanding for ALMKS has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALMKS has an improved debt to assets ratio.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.79, we must say that ALMKS is in the distress zone and has some risk of bankruptcy.
  • ALMKS has a Altman-Z score of 1.79. This is in the better half of the industry: ALMKS outperforms 60.94% of its industry peers.
  • ALMKS has a debt to FCF ratio of 1.06. This is a very positive value and a sign of high solvency as it would only need 1.06 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.06, ALMKS belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • ALMKS has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.21, ALMKS is in the better half of the industry, outperforming 70.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Altman-Z 1.79
ROIC/WACC1.03
WACC6.83%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.84 indicates that ALMKS may have some problems paying its short term obligations.
  • ALMKS has a worse Current ratio (0.84) than 62.50% of its industry peers.
  • ALMKS has a Quick Ratio of 0.84. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALMKS has a Quick ratio (0.82) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.82
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.80%, which is quite impressive.
  • ALMKS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 64.14% yearly.
  • ALMKS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.02%.
  • The Revenue has been growing by 43.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%

3.2 Future

  • Based on estimates for the next years, ALMKS will show a very negative growth in Earnings Per Share. The EPS will decrease by -63.53% on average per year.
  • ALMKS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.23% yearly.
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMKS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • ALMKS is valuated quite expensively with a Price/Forward Earnings ratio of 70.41.
  • Based on the Price/Forward Earnings ratio, ALMKS is valued a bit more expensive than the industry average as 64.06% of the companies are valued more cheaply.
  • ALMKS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 70.41
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALMKS is valued a bit cheaper than 62.50% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALMKS indicates a rather cheap valuation: ALMKS is cheaper than 98.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.87
EV/EBITDA 5.78
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ALMKS's earnings are expected to decrease with -63.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.53%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • ALMKS has a Yearly Dividend Yield of 2.26%.
  • ALMKS's Dividend Yield is comparable with the industry average which is at 3.32.
  • Compared to an average S&P500 Dividend Yield of 1.81, ALMKS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALMKS.PA Yearly Dividends per shareALMKS.PA Yearly Dividends per shareYearly Dividends per share 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y-63.53%
EPS Next 3YN/A
ALMKS.PA Yearly Income VS Free CF VS DividendALMKS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (4/24/2026, 7:00:00 PM)

7.9

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners4.21%
Inst Owner ChangeN/A
Ins Owners58.8%
Ins Owner ChangeN/A
Market Cap71.81M
Revenue(TTM)273.54M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-70.27%
EPS NY rev (3m)-73.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.41
P/S 0.26
P/FCF 1.87
P/OCF 1.86
P/B 1.87
P/tB N/A
EV/EBITDA 5.78
EPS(TTM)-0.19
EYN/A
EPS(NY)0.11
Fwd EY1.42%
FCF(TTM)4.22
FCFY53.44%
OCF(TTM)4.24
OCFY53.68%
SpS30.09
BVpS4.22
TBVpS-2.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROCE 9.53%
ROIC 7%
ROICexc 19.52%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.58%
FCFM 14.03%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ROICexc(3y)5.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
F-Score6
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Debt/EBITDA 0.63
Cap/Depr 2.28%
Cap/Sales 0.06%
Interest Coverage 1.19
Cash Conversion 304.51%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.82
Altman-Z 1.79
F-Score6
WACC6.83%
ROIC/WACC1.03
Cap/Depr(3y)8.61%
Cap/Depr(5y)162.22%
Cap/Sales(3y)0.2%
Cap/Sales(5y)5.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y279.09%
EBIT growth 3YN/A
EBIT growth 5Y-40.98%
EBIT Next Year83.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76352.4%
FCF growth 3Y58.75%
FCF growth 5YN/A
OCF growth 1Y11729.2%
OCF growth 3Y52.22%
OCF growth 5Y61.77%

MAKING SCIENCE GROUP SA / ALMKS.PA Fundamental Analysis FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 2 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


How profitable is MAKING SCIENCE GROUP SA (ALMKS.PA) stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 3 / 10.